Epalrestat
Epalrestat CAS Nr .: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat lieto, lai novērstu, uzlabotu un ārstētu perifēro neiropātiju (nejutīgumu, sāpes), vibrācijas parestēziju un sirds anomālijas, kas saistītas ar diabētu. SPECIFIKĀCIJA
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat lieto, lai novērstu, uzlabotu un ārstētu perifēro neiropātiju (nejutīgumu, sāpes), vibrācijas parestēziju un sirds anomālijas, kas saistītas ar diabētu. SPECIFIKĀCIJA
P rodukta nosaukums | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319.4 |
Uzrakstiet savu ziņojumu šeit un nosūtiet to mums